Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications.
Kochhar GS, Desai A, Syed A, Grover A, El Hachem S, Abdul-Baki H, Chintamaneni P, Aoun E, Kanna S, Sandhu DS, Singh S, Shen B, Loftus EV Jr, Dulai PS.
Kochhar GS, et al. Among authors: desai a.
Aliment Pharmacol Ther. 2020 Jun;51(11):1067-1075. doi: 10.1111/apt.15721. Epub 2020 Apr 21.
Aliment Pharmacol Ther. 2020.
PMID: 32319111